Return to Clinical Trials Search Results

ELUCIDATE FFRCT Study

To evaluate the diagnostic accuracy of a plaque-based coronary CT angiography (CCTA) fractional flow reserve (FFRCT) software device (ElucidVivoTM) as compared to invasive fractional flow reserve (FFR) in patients who underwent clinically indicated CCTA and invasive FFR.

Phase

Unspecified

Recruitment Status

Past Studies

View on
ClinicalTrials.gov